Transaction · 0001434647-26-000075

McFarlane Neil F.

McFarlane Neil F., PRES, reported a transaction classified as exercise at ZEVRA THERAPEUTICS, INC. involving 50000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 50000.000000 shares. The stored filing text includes a detected 10b5-1 reference.

exerciseSEC transaction code MPRES
ZVRAZEVRA THERAPEUTICS, INC.
Trade date
Oct 10, 2026
Filing date
Oct 13, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded50.0k$0.00 per share
Holdings after50.0kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

ZVRA price since this filing

Daily closing prices, with the filing date and available return windows
ZVRA · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +3.5%1w ago +0.0%1d ago +0.0%
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0001434647-26-000075
Restricted Stock Unit
Transaction date
Oct 10, 2026
Filed Oct 13, 2026, 08:24 PM · 3d delay
Shares
50,000 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
50,000 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Reduction 10b5-1 Detected
Filing-only score

-20 points

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.

  2. F2

    Adoption date of referenced 10b5-1(c) plan is: 03-25-2026

  3. F3

    This transaction was executed in multiple trades at prices ranging from $11.07 to $11.36. The price reported reflects the weighted average sale price. The Reporting Person undertakes to provide upon r…

  4. F4

    25% of the RSUs vested and settled on each of October 10, 2024, October 10, 2025 and October 10, 2026. The remaining 25% of the shares will vest on 10/10/2027, provided that at the relevant vesting da…

Original filing · 0001434647-26-000075
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

ZVRA